Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 174

1.

Precise therapeutic gene correction by a simple nuclease-induced double-stranded break.

Iyer S, Suresh S, Guo D, Daman K, Chen JCJ, Liu P, Zieger M, Luk K, Roscoe BP, Mueller C, King OD, Emerson CP Jr, Wolfe SA.

Nature. 2019 Apr 3. doi: 10.1038/s41586-019-1076-8. [Epub ahead of print]

PMID:
30944467
2.

Radiographic Musculoskeletal Findings Indicating Opioid Misuse: An Overview for Orthopedic Surgeons.

Greditzer HG 4th, Massel DH, Barrera CM, Emerson CP, Rizzo MG, Ezuddin N, Brasil C, Nuno AU, Jose J.

HSS J. 2019 Feb;15(1):84-92. doi: 10.1007/s11420-018-09654-y. Epub 2019 Jan 8. Review.

PMID:
30863238
3.

Systemic Complications and Radiographic Findings of Opioid Use and Misuse: An Overview for Orthopedic Surgeons.

Greditzer HG 4th, Massel DH, Barrera CM, Ezuddin NS, Emerson CP, Jose J.

HSS J. 2019 Feb;15(1):76-83. doi: 10.1007/s11420-018-9649-x. Epub 2018 Dec 7. Review.

PMID:
30863237
4.

Facioscapulohumeral Muscular Dystrophy.

DeSimone AM, Pakula A, Lek A, Emerson CP Jr.

Compr Physiol. 2017 Sep 12;7(4):1229-1279. doi: 10.1002/cphy.c160039. Review.

PMID:
28915324
5.

Efficacy of fractional lasers in treating alopecia: a literature review.

Perper M, Aldahan AS, Fayne RA, Emerson CP, Nouri K.

Lasers Med Sci. 2017 Nov;32(8):1919-1925. doi: 10.1007/s10103-017-2306-7. Epub 2017 Aug 16. Review.

PMID:
28812164
6.

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion.

Mou H, Smith JL, Peng L, Yin H, Moore J, Zhang XO, Song CQ, Sheel A, Wu Q, Ozata DM, Li Y, Anderson DG, Emerson CP, Sontheimer EJ, Moore MJ, Weng Z, Xue W.

Genome Biol. 2017 Jun 14;18(1):108. doi: 10.1186/s13059-017-1237-8.

7.

Cells to Surgery Quiz: September 2016.

Perper M, Emerson CP, Fayne RA, Molla A, Aldahan AS, Tsatalis JP, Nouri K.

J Invest Dermatol. 2016 Sep;136(9):e97. doi: 10.1016/j.jid.2016.07.007. Epub 2016 Aug 16. No abstract available.

8.

Cells to Surgery Quiz: August 2016.

Tsatalis JP, Perper M, Aldahan AS, Emerson CP, Molla A, Nouri K.

J Invest Dermatol. 2016 Aug;136(8):e85. doi: 10.1016/j.jid.2016.06.005. Epub 2016 Jul 20. No abstract available.

9.

Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics.

Chen JC, King OD, Zhang Y, Clayton NP, Spencer C, Wentworth BM, Emerson CP Jr, Wagner KR.

Mol Ther. 2016 Aug;24(8):1405-11. doi: 10.1038/mt.2016.111. Epub 2016 Jun 3.

10.

Howard Holtzer -- developmental and cell biologist 1922-2014.

Stockdale FE, Sanger JW, Emerson CP Jr.

Dev Biol. 2015 May 15;401(2):185-7. doi: 10.1016/j.ydbio.2015.04.004. No abstract available.

11.

Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.

Jones TI, King OD, Himeda CL, Homma S, Chen JC, Beermann ML, Yan C, Emerson CP Jr, Miller JB, Wagner KR, Jones PL.

Clin Epigenetics. 2015 Mar 29;7:37. doi: 10.1186/s13148-015-0072-6. eCollection 2015.

12.

Tom D. Humphreys II: a pioneer of molecular embryology.

Brandhorst BP, Emerson CP Jr.

Mol Reprod Dev. 2014 Aug;81(8):Fmi. doi: 10.1002/mrd.22248. No abstract available.

PMID:
25123476
13.

Human skeletal muscle xenograft as a new preclinical model for muscle disorders.

Zhang Y, King OD, Rahimov F, Jones TI, Ward CW, Kerr JP, Liu N, Emerson CP Jr, Kunkel LM, Partridge TA, Wagner KR.

Hum Mol Genet. 2014 Jun 15;23(12):3180-8. doi: 10.1093/hmg/ddu028. Epub 2014 Jan 22.

14.

A new role for Hedgehogs in juxtacrine signaling.

Pettigrew CA, Asp E, Emerson CP Jr.

Mech Dev. 2014 Feb;131:137-49. doi: 10.1016/j.mod.2013.12.002. Epub 2013 Dec 14.

15.

Pax3 synergizes with Gli2 and Zic1 in transactivating the Myf5 epaxial somite enhancer.

Himeda CL, Barro MV, Emerson CP Jr.

Dev Biol. 2013 Nov 1;383(1):7-14. doi: 10.1016/j.ydbio.2013.09.006. Epub 2013 Sep 10.

16.

Telomere position effect regulates DUX4 in human facioscapulohumeral muscular dystrophy.

Stadler G, Rahimov F, King OD, Chen JC, Robin JD, Wagner KR, Shay JW, Emerson CP Jr, Wright WE.

Nat Struct Mol Biol. 2013 Jun;20(6):671-8. doi: 10.1038/nsmb.2571. Epub 2013 May 5.

17.

Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers.

Rahimov F, King OD, Leung DG, Bibat GM, Emerson CP Jr, Kunkel LM, Wagner KR.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16234-9. doi: 10.1073/pnas.1209508109. Epub 2012 Sep 17.

18.

Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.

Jones TI, Chen JC, Rahimov F, Homma S, Arashiro P, Beermann ML, King OD, Miller JB, Kunkel LM, Emerson CP Jr, Wagner KR, Jones PL.

Hum Mol Genet. 2012 Oct 15;21(20):4419-30. Epub 2012 Jul 13.

19.

A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function.

Homma S, Chen JC, Rahimov F, Beermann ML, Hanger K, Bibat GM, Wagner KR, Kunkel LM, Emerson CP Jr, Miller JB.

Eur J Hum Genet. 2012 Apr;20(4):404-10. doi: 10.1038/ejhg.2011.213. Epub 2011 Nov 23.

20.

Establishment of clonal myogenic cell lines from severely affected dystrophic muscles - CDK4 maintains the myogenic population.

Stadler G, Chen JC, Wagner K, Robin JD, Shay JW, Emerson CP Jr, Wright WE.

Skelet Muscle. 2011 Mar 8;1(1):12. doi: 10.1186/2044-5040-1-12.

Supplemental Content

Loading ...
Support Center